nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—blood vessel—Alzheimer's disease	0.0127	0.0708	CbGeAlD
Pentoxifylline—NT5E—embryo—Alzheimer's disease	0.0117	0.065	CbGeAlD
Pentoxifylline—NT5E—telencephalon—Alzheimer's disease	0.00949	0.0529	CbGeAlD
Pentoxifylline—ADORA2A—forebrain—Alzheimer's disease	0.00736	0.041	CbGeAlD
Pentoxifylline—PDE4A—telencephalon—Alzheimer's disease	0.00725	0.0404	CbGeAlD
Pentoxifylline—ADORA2A—telencephalon—Alzheimer's disease	0.00676	0.0377	CbGeAlD
Pentoxifylline—PDE5A—forebrain—Alzheimer's disease	0.0067	0.0373	CbGeAlD
Pentoxifylline—ADORA1—forebrain—Alzheimer's disease	0.00635	0.0354	CbGeAlD
Pentoxifylline—PDE5A—telencephalon—Alzheimer's disease	0.00616	0.0343	CbGeAlD
Pentoxifylline—ADORA1—telencephalon—Alzheimer's disease	0.00584	0.0325	CbGeAlD
Pentoxifylline—NT5E—nervous system—Alzheimer's disease	0.0056	0.0312	CbGeAlD
Pentoxifylline—NT5E—central nervous system—Alzheimer's disease	0.0054	0.0301	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—Alzheimer's disease	0.0048	0.0267	CbGeAlD
Pentoxifylline—PDE4B—forebrain—Alzheimer's disease	0.0047	0.0262	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—Alzheimer's disease	0.00462	0.0257	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—Alzheimer's disease	0.00452	0.0252	CbGeAlD
Pentoxifylline—PDE4B—telencephalon—Alzheimer's disease	0.00432	0.0241	CbGeAlD
Pentoxifylline—NT5E—brain—Alzheimer's disease	0.00428	0.0239	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—Alzheimer's disease	0.00403	0.0224	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—Alzheimer's disease	0.00399	0.0222	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—Alzheimer's disease	0.00384	0.0214	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—Alzheimer's disease	0.00376	0.0209	CbGeAlD
Pentoxifylline—ADORA2B—brain—Alzheimer's disease	0.00367	0.0204	CbGeAlD
Pentoxifylline—PDE5A—nervous system—Alzheimer's disease	0.00364	0.0203	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—Alzheimer's disease	0.0035	0.0195	CbGeAlD
Pentoxifylline—ADORA1—nervous system—Alzheimer's disease	0.00345	0.0192	CbGeAlD
Pentoxifylline—PDE5A—cerebellum—Alzheimer's disease	0.00342	0.0191	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—Alzheimer's disease	0.00332	0.0185	CbGeAlD
Pentoxifylline—PDE4A—brain—Alzheimer's disease	0.00327	0.0182	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—Alzheimer's disease	0.00324	0.0181	CbGeAlD
Pentoxifylline—ADORA2A—brain—Alzheimer's disease	0.00305	0.017	CbGeAlD
Pentoxifylline—PDE5A—brain—Alzheimer's disease	0.00278	0.0155	CbGeAlD
Pentoxifylline—ADORA1—brain—Alzheimer's disease	0.00264	0.0147	CbGeAlD
Pentoxifylline—Hepatitis—Galantamine—Alzheimer's disease	0.00255	0.0048	CcSEcCtD
Pentoxifylline—Haemorrhage—Galantamine—Alzheimer's disease	0.00255	0.0048	CcSEcCtD
Pentoxifylline—PDE4B—nervous system—Alzheimer's disease	0.00255	0.0142	CbGeAlD
Pentoxifylline—Abdominal distension—Donepezil—Alzheimer's disease	0.00249	0.00468	CcSEcCtD
Pentoxifylline—PDE4B—central nervous system—Alzheimer's disease	0.00246	0.0137	CbGeAlD
Pentoxifylline—Angina pectoris—Donepezil—Alzheimer's disease	0.00241	0.00453	CcSEcCtD
Pentoxifylline—PDE4B—cerebellum—Alzheimer's disease	0.0024	0.0134	CbGeAlD
Pentoxifylline—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00237	0.00445	CcSEcCtD
Pentoxifylline—Flushing—Galantamine—Alzheimer's disease	0.00237	0.00445	CcSEcCtD
Pentoxifylline—Immune system disorder—Galantamine—Alzheimer's disease	0.00231	0.00433	CcSEcCtD
Pentoxifylline—Arrhythmia—Galantamine—Alzheimer's disease	0.00228	0.00429	CcSEcCtD
Pentoxifylline—Bronchospasm—Memantine—Alzheimer's disease	0.00221	0.00415	CcSEcCtD
Pentoxifylline—Infestation—Donepezil—Alzheimer's disease	0.0022	0.00414	CcSEcCtD
Pentoxifylline—Infestation NOS—Donepezil—Alzheimer's disease	0.0022	0.00414	CcSEcCtD
Pentoxifylline—Flatulence—Galantamine—Alzheimer's disease	0.00219	0.00412	CcSEcCtD
Pentoxifylline—Angina pectoris—Memantine—Alzheimer's disease	0.00219	0.00411	CcSEcCtD
Pentoxifylline—Tension—Galantamine—Alzheimer's disease	0.00218	0.0041	CcSEcCtD
Pentoxifylline—Dysgeusia—Galantamine—Alzheimer's disease	0.00218	0.00409	CcSEcCtD
Pentoxifylline—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00216	0.00406	CcSEcCtD
Pentoxifylline—Nervousness—Galantamine—Alzheimer's disease	0.00216	0.00406	CcSEcCtD
Pentoxifylline—Back pain—Galantamine—Alzheimer's disease	0.00215	0.00404	CcSEcCtD
Pentoxifylline—Jaundice—Donepezil—Alzheimer's disease	0.00215	0.00404	CcSEcCtD
Pentoxifylline—Conjunctivitis—Donepezil—Alzheimer's disease	0.00214	0.00403	CcSEcCtD
Pentoxifylline—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00214	0.00402	CcSEcCtD
Pentoxifylline—Muscle spasms—Galantamine—Alzheimer's disease	0.00214	0.00402	CcSEcCtD
Pentoxifylline—Pancytopenia—Memantine—Alzheimer's disease	0.00213	0.00401	CcSEcCtD
Pentoxifylline—Sweating—Donepezil—Alzheimer's disease	0.00211	0.00397	CcSEcCtD
Pentoxifylline—Vision blurred—Galantamine—Alzheimer's disease	0.00209	0.00394	CcSEcCtD
Pentoxifylline—Tremor—Galantamine—Alzheimer's disease	0.00208	0.00391	CcSEcCtD
Pentoxifylline—Epistaxis—Donepezil—Alzheimer's disease	0.00208	0.00391	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00206	0.00388	CcSEcCtD
Pentoxifylline—Anaemia—Galantamine—Alzheimer's disease	0.00205	0.00386	CcSEcCtD
Pentoxifylline—Agitation—Galantamine—Alzheimer's disease	0.00204	0.00384	CcSEcCtD
Pentoxifylline—Malaise—Galantamine—Alzheimer's disease	0.002	0.00377	CcSEcCtD
Pentoxifylline—Infestation NOS—Memantine—Alzheimer's disease	0.002	0.00376	CcSEcCtD
Pentoxifylline—Infestation—Memantine—Alzheimer's disease	0.002	0.00376	CcSEcCtD
Pentoxifylline—Haemoglobin—Donepezil—Alzheimer's disease	0.00199	0.00374	CcSEcCtD
Pentoxifylline—Hepatitis—Donepezil—Alzheimer's disease	0.00198	0.00372	CcSEcCtD
Pentoxifylline—Haemorrhage—Donepezil—Alzheimer's disease	0.00198	0.00372	CcSEcCtD
Pentoxifylline—Palpitations—Galantamine—Alzheimer's disease	0.00196	0.00369	CcSEcCtD
Pentoxifylline—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00196	0.00368	CcSEcCtD
Pentoxifylline—Infestation—Rivastigmine—Alzheimer's disease	0.00196	0.00368	CcSEcCtD
Pentoxifylline—Drowsiness—Rivastigmine—Alzheimer's disease	0.00196	0.00368	CcSEcCtD
Pentoxifylline—PDE4B—brain—Alzheimer's disease	0.00195	0.0109	CbGeAlD
Pentoxifylline—Conjunctivitis—Memantine—Alzheimer's disease	0.00194	0.00366	CcSEcCtD
Pentoxifylline—Convulsion—Galantamine—Alzheimer's disease	0.00193	0.00362	CcSEcCtD
Pentoxifylline—Hypertension—Galantamine—Alzheimer's disease	0.00192	0.00361	CcSEcCtD
Pentoxifylline—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.0019	0.00358	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00189	0.00356	CcSEcCtD
Pentoxifylline—Chest pain—Galantamine—Alzheimer's disease	0.00189	0.00356	CcSEcCtD
Pentoxifylline—Myalgia—Galantamine—Alzheimer's disease	0.00189	0.00356	CcSEcCtD
Pentoxifylline—Epistaxis—Memantine—Alzheimer's disease	0.00189	0.00355	CcSEcCtD
Pentoxifylline—Anxiety—Galantamine—Alzheimer's disease	0.00189	0.00354	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00188	0.00353	CcSEcCtD
Pentoxifylline—Sweating—Rivastigmine—Alzheimer's disease	0.00188	0.00353	CcSEcCtD
Pentoxifylline—Discomfort—Galantamine—Alzheimer's disease	0.00187	0.00351	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00185	0.00348	CcSEcCtD
Pentoxifylline—Dry mouth—Galantamine—Alzheimer's disease	0.00185	0.00348	CcSEcCtD
Pentoxifylline—Epistaxis—Rivastigmine—Alzheimer's disease	0.00185	0.00347	CcSEcCtD
Pentoxifylline—Confusional state—Galantamine—Alzheimer's disease	0.00183	0.00344	CcSEcCtD
Pentoxifylline—Haemoglobin—Memantine—Alzheimer's disease	0.00181	0.00339	CcSEcCtD
Pentoxifylline—Hepatitis—Memantine—Alzheimer's disease	0.0018	0.00338	CcSEcCtD
Pentoxifylline—Haemorrhage—Memantine—Alzheimer's disease	0.0018	0.00338	CcSEcCtD
Pentoxifylline—Shock—Galantamine—Alzheimer's disease	0.00178	0.00335	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00178	0.00334	CcSEcCtD
Pentoxifylline—Tachycardia—Galantamine—Alzheimer's disease	0.00177	0.00333	CcSEcCtD
Pentoxifylline—Arrhythmia—Donepezil—Alzheimer's disease	0.00177	0.00332	CcSEcCtD
Pentoxifylline—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00177	0.00332	CcSEcCtD
Pentoxifylline—Skin disorder—Galantamine—Alzheimer's disease	0.00176	0.00331	CcSEcCtD
Pentoxifylline—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00176	0.0033	CcSEcCtD
Pentoxifylline—Hepatitis—Rivastigmine—Alzheimer's disease	0.00176	0.0033	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00175	0.0033	CcSEcCtD
Pentoxifylline—Anorexia—Galantamine—Alzheimer's disease	0.00173	0.00325	CcSEcCtD
Pentoxifylline—Erythema—Donepezil—Alzheimer's disease	0.00172	0.00324	CcSEcCtD
Pentoxifylline—Flatulence—Donepezil—Alzheimer's disease	0.0017	0.00319	CcSEcCtD
Pentoxifylline—Hypotension—Galantamine—Alzheimer's disease	0.00169	0.00319	CcSEcCtD
Pentoxifylline—Tension—Donepezil—Alzheimer's disease	0.00169	0.00318	CcSEcCtD
Pentoxifylline—Dysgeusia—Donepezil—Alzheimer's disease	0.00169	0.00317	CcSEcCtD
Pentoxifylline—Nervousness—Donepezil—Alzheimer's disease	0.00167	0.00314	CcSEcCtD
Pentoxifylline—Flushing—Memantine—Alzheimer's disease	0.00167	0.00313	CcSEcCtD
Pentoxifylline—Back pain—Donepezil—Alzheimer's disease	0.00167	0.00313	CcSEcCtD
Pentoxifylline—Muscle spasms—Donepezil—Alzheimer's disease	0.00166	0.00311	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00165	0.00311	CcSEcCtD
Pentoxifylline—Insomnia—Galantamine—Alzheimer's disease	0.00164	0.00308	CcSEcCtD
Pentoxifylline—Flushing—Rivastigmine—Alzheimer's disease	0.00163	0.00307	CcSEcCtD
Pentoxifylline—Vision blurred—Donepezil—Alzheimer's disease	0.00162	0.00305	CcSEcCtD
Pentoxifylline—Immune system disorder—Memantine—Alzheimer's disease	0.00162	0.00305	CcSEcCtD
Pentoxifylline—Tremor—Donepezil—Alzheimer's disease	0.00161	0.00303	CcSEcCtD
Pentoxifylline—Somnolence—Galantamine—Alzheimer's disease	0.00161	0.00303	CcSEcCtD
Pentoxifylline—Arrhythmia—Memantine—Alzheimer's disease	0.0016	0.00302	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Donepezil—Alzheimer's disease	0.0016	0.003	CcSEcCtD
Pentoxifylline—Dyspepsia—Galantamine—Alzheimer's disease	0.0016	0.003	CcSEcCtD
Pentoxifylline—Anaemia—Donepezil—Alzheimer's disease	0.00159	0.00299	CcSEcCtD
Pentoxifylline—Agitation—Donepezil—Alzheimer's disease	0.00158	0.00298	CcSEcCtD
Pentoxifylline—Decreased appetite—Galantamine—Alzheimer's disease	0.00158	0.00296	CcSEcCtD
Pentoxifylline—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00157	0.00295	CcSEcCtD
Pentoxifylline—Malaise—Donepezil—Alzheimer's disease	0.00155	0.00292	CcSEcCtD
Pentoxifylline—Constipation—Galantamine—Alzheimer's disease	0.00155	0.00292	CcSEcCtD
Pentoxifylline—Flatulence—Memantine—Alzheimer's disease	0.00154	0.0029	CcSEcCtD
Pentoxifylline—Tension—Memantine—Alzheimer's disease	0.00153	0.00288	CcSEcCtD
Pentoxifylline—Dysgeusia—Memantine—Alzheimer's disease	0.00153	0.00288	CcSEcCtD
Pentoxifylline—Erythema—Rivastigmine—Alzheimer's disease	0.00153	0.00288	CcSEcCtD
Pentoxifylline—Nervousness—Memantine—Alzheimer's disease	0.00152	0.00285	CcSEcCtD
Pentoxifylline—Back pain—Memantine—Alzheimer's disease	0.00151	0.00284	CcSEcCtD
Pentoxifylline—Flatulence—Rivastigmine—Alzheimer's disease	0.00151	0.00283	CcSEcCtD
Pentoxifylline—Tension—Rivastigmine—Alzheimer's disease	0.0015	0.00282	CcSEcCtD
Pentoxifylline—Dysgeusia—Rivastigmine—Alzheimer's disease	0.0015	0.00282	CcSEcCtD
Pentoxifylline—Feeling abnormal—Galantamine—Alzheimer's disease	0.00149	0.00281	CcSEcCtD
Pentoxifylline—Convulsion—Donepezil—Alzheimer's disease	0.00149	0.0028	CcSEcCtD
Pentoxifylline—Hypertension—Donepezil—Alzheimer's disease	0.00149	0.0028	CcSEcCtD
Pentoxifylline—Nervousness—Rivastigmine—Alzheimer's disease	0.00149	0.00279	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00148	0.00279	CcSEcCtD
Pentoxifylline—Back pain—Rivastigmine—Alzheimer's disease	0.00148	0.00278	CcSEcCtD
Pentoxifylline—Vision blurred—Memantine—Alzheimer's disease	0.00147	0.00277	CcSEcCtD
Pentoxifylline—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00147	0.00276	CcSEcCtD
Pentoxifylline—Myalgia—Donepezil—Alzheimer's disease	0.00147	0.00276	CcSEcCtD
Pentoxifylline—Chest pain—Donepezil—Alzheimer's disease	0.00147	0.00276	CcSEcCtD
Pentoxifylline—Tremor—Memantine—Alzheimer's disease	0.00146	0.00275	CcSEcCtD
Pentoxifylline—Anxiety—Donepezil—Alzheimer's disease	0.00146	0.00275	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Memantine—Alzheimer's disease	0.00145	0.00273	CcSEcCtD
Pentoxifylline—Discomfort—Donepezil—Alzheimer's disease	0.00145	0.00272	CcSEcCtD
Pentoxifylline—Anaemia—Memantine—Alzheimer's disease	0.00145	0.00272	CcSEcCtD
Pentoxifylline—Vision blurred—Rivastigmine—Alzheimer's disease	0.00144	0.00271	CcSEcCtD
Pentoxifylline—Agitation—Memantine—Alzheimer's disease	0.00144	0.0027	CcSEcCtD
Pentoxifylline—Dry mouth—Donepezil—Alzheimer's disease	0.00143	0.0027	CcSEcCtD
Pentoxifylline—Body temperature increased—Galantamine—Alzheimer's disease	0.00143	0.0027	CcSEcCtD
Pentoxifylline—Abdominal pain—Galantamine—Alzheimer's disease	0.00143	0.0027	CcSEcCtD
Pentoxifylline—Tremor—Rivastigmine—Alzheimer's disease	0.00143	0.00269	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00142	0.00267	CcSEcCtD
Pentoxifylline—Confusional state—Donepezil—Alzheimer's disease	0.00142	0.00266	CcSEcCtD
Pentoxifylline—Anaemia—Rivastigmine—Alzheimer's disease	0.00141	0.00266	CcSEcCtD
Pentoxifylline—Malaise—Memantine—Alzheimer's disease	0.00141	0.00265	CcSEcCtD
Pentoxifylline—Agitation—Rivastigmine—Alzheimer's disease	0.00141	0.00264	CcSEcCtD
Pentoxifylline—Oedema—Donepezil—Alzheimer's disease	0.00141	0.00264	CcSEcCtD
Pentoxifylline—Leukopenia—Memantine—Alzheimer's disease	0.0014	0.00263	CcSEcCtD
Pentoxifylline—Infection—Donepezil—Alzheimer's disease	0.0014	0.00262	CcSEcCtD
Pentoxifylline—Shock—Donepezil—Alzheimer's disease	0.00138	0.0026	CcSEcCtD
Pentoxifylline—Palpitations—Memantine—Alzheimer's disease	0.00138	0.0026	CcSEcCtD
Pentoxifylline—Malaise—Rivastigmine—Alzheimer's disease	0.00138	0.00259	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00138	0.00259	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00136	0.00255	CcSEcCtD
Pentoxifylline—Convulsion—Memantine—Alzheimer's disease	0.00135	0.00255	CcSEcCtD
Pentoxifylline—Palpitations—Rivastigmine—Alzheimer's disease	0.00135	0.00254	CcSEcCtD
Pentoxifylline—Hypertension—Memantine—Alzheimer's disease	0.00135	0.00254	CcSEcCtD
Pentoxifylline—Anorexia—Donepezil—Alzheimer's disease	0.00134	0.00252	CcSEcCtD
Pentoxifylline—Hypersensitivity—Galantamine—Alzheimer's disease	0.00134	0.00251	CcSEcCtD
Pentoxifylline—Chest pain—Memantine—Alzheimer's disease	0.00133	0.0025	CcSEcCtD
Pentoxifylline—Myalgia—Memantine—Alzheimer's disease	0.00133	0.0025	CcSEcCtD
Pentoxifylline—Anxiety—Memantine—Alzheimer's disease	0.00133	0.00249	CcSEcCtD
Pentoxifylline—Convulsion—Rivastigmine—Alzheimer's disease	0.00133	0.00249	CcSEcCtD
Pentoxifylline—Hypertension—Rivastigmine—Alzheimer's disease	0.00132	0.00248	CcSEcCtD
Pentoxifylline—Discomfort—Memantine—Alzheimer's disease	0.00132	0.00247	CcSEcCtD
Pentoxifylline—Hypotension—Donepezil—Alzheimer's disease	0.00131	0.00247	CcSEcCtD
Pentoxifylline—Chest pain—Rivastigmine—Alzheimer's disease	0.0013	0.00245	CcSEcCtD
Pentoxifylline—Myalgia—Rivastigmine—Alzheimer's disease	0.0013	0.00245	CcSEcCtD
Pentoxifylline—Dry mouth—Memantine—Alzheimer's disease	0.0013	0.00245	CcSEcCtD
Pentoxifylline—Asthenia—Galantamine—Alzheimer's disease	0.0013	0.00245	CcSEcCtD
Pentoxifylline—Anxiety—Rivastigmine—Alzheimer's disease	0.0013	0.00244	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00129	0.00243	CcSEcCtD
Pentoxifylline—Confusional state—Memantine—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Pentoxifylline—Discomfort—Rivastigmine—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00128	0.00241	CcSEcCtD
Pentoxifylline—Oedema—Memantine—Alzheimer's disease	0.00128	0.0024	CcSEcCtD
Pentoxifylline—Dry mouth—Rivastigmine—Alzheimer's disease	0.00127	0.00239	CcSEcCtD
Pentoxifylline—Insomnia—Donepezil—Alzheimer's disease	0.00127	0.00239	CcSEcCtD
Pentoxifylline—Infection—Memantine—Alzheimer's disease	0.00127	0.00238	CcSEcCtD
Pentoxifylline—Confusional state—Rivastigmine—Alzheimer's disease	0.00126	0.00237	CcSEcCtD
Pentoxifylline—Shock—Memantine—Alzheimer's disease	0.00126	0.00236	CcSEcCtD
Pentoxifylline—Dyspnoea—Donepezil—Alzheimer's disease	0.00125	0.00236	CcSEcCtD
Pentoxifylline—Somnolence—Donepezil—Alzheimer's disease	0.00125	0.00235	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Memantine—Alzheimer's disease	0.00125	0.00235	CcSEcCtD
Pentoxifylline—Oedema—Rivastigmine—Alzheimer's disease	0.00125	0.00235	CcSEcCtD
Pentoxifylline—Tachycardia—Memantine—Alzheimer's disease	0.00125	0.00234	CcSEcCtD
Pentoxifylline—Diarrhoea—Galantamine—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Pentoxifylline—Infection—Rivastigmine—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Pentoxifylline—Skin disorder—Memantine—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Pentoxifylline—Dyspepsia—Donepezil—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Memantine—Alzheimer's disease	0.00123	0.00232	CcSEcCtD
Pentoxifylline—Shock—Rivastigmine—Alzheimer's disease	0.00123	0.00231	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00122	0.0023	CcSEcCtD
Pentoxifylline—Decreased appetite—Donepezil—Alzheimer's disease	0.00122	0.0023	CcSEcCtD
Pentoxifylline—Tachycardia—Rivastigmine—Alzheimer's disease	0.00122	0.00229	CcSEcCtD
Pentoxifylline—Anorexia—Memantine—Alzheimer's disease	0.00122	0.00229	CcSEcCtD
Pentoxifylline—Skin disorder—Rivastigmine—Alzheimer's disease	0.00121	0.00228	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00121	0.00227	CcSEcCtD
Pentoxifylline—Constipation—Donepezil—Alzheimer's disease	0.0012	0.00226	CcSEcCtD
Pentoxifylline—Dizziness—Galantamine—Alzheimer's disease	0.0012	0.00225	CcSEcCtD
Pentoxifylline—Hypotension—Memantine—Alzheimer's disease	0.00119	0.00224	CcSEcCtD
Pentoxifylline—Anorexia—Rivastigmine—Alzheimer's disease	0.00119	0.00224	CcSEcCtD
Pentoxifylline—Hypotension—Rivastigmine—Alzheimer's disease	0.00117	0.00219	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00116	0.00219	CcSEcCtD
Pentoxifylline—Feeling abnormal—Donepezil—Alzheimer's disease	0.00116	0.00218	CcSEcCtD
Pentoxifylline—Insomnia—Memantine—Alzheimer's disease	0.00115	0.00217	CcSEcCtD
Pentoxifylline—Vomiting—Galantamine—Alzheimer's disease	0.00115	0.00217	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00115	0.00216	CcSEcCtD
Pentoxifylline—Rash—Galantamine—Alzheimer's disease	0.00114	0.00215	CcSEcCtD
Pentoxifylline—Dermatitis—Galantamine—Alzheimer's disease	0.00114	0.00215	CcSEcCtD
Pentoxifylline—Dyspnoea—Memantine—Alzheimer's disease	0.00114	0.00214	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00114	0.00214	CcSEcCtD
Pentoxifylline—Headache—Galantamine—Alzheimer's disease	0.00114	0.00214	CcSEcCtD
Pentoxifylline—Somnolence—Memantine—Alzheimer's disease	0.00113	0.00213	CcSEcCtD
Pentoxifylline—Insomnia—Rivastigmine—Alzheimer's disease	0.00113	0.00212	CcSEcCtD
Pentoxifylline—Dyspepsia—Memantine—Alzheimer's disease	0.00112	0.00211	CcSEcCtD
Pentoxifylline—Urticaria—Donepezil—Alzheimer's disease	0.00112	0.0021	CcSEcCtD
Pentoxifylline—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00111	0.00209	CcSEcCtD
Pentoxifylline—Body temperature increased—Donepezil—Alzheimer's disease	0.00111	0.00209	CcSEcCtD
Pentoxifylline—Abdominal pain—Donepezil—Alzheimer's disease	0.00111	0.00209	CcSEcCtD
Pentoxifylline—Somnolence—Rivastigmine—Alzheimer's disease	0.00111	0.00209	CcSEcCtD
Pentoxifylline—Decreased appetite—Memantine—Alzheimer's disease	0.00111	0.00209	CcSEcCtD
Pentoxifylline—Dyspepsia—Rivastigmine—Alzheimer's disease	0.0011	0.00207	CcSEcCtD
Pentoxifylline—Constipation—Memantine—Alzheimer's disease	0.00109	0.00205	CcSEcCtD
Pentoxifylline—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00109	0.00204	CcSEcCtD
Pentoxifylline—Nausea—Galantamine—Alzheimer's disease	0.00108	0.00203	CcSEcCtD
Pentoxifylline—Constipation—Rivastigmine—Alzheimer's disease	0.00107	0.00201	CcSEcCtD
Pentoxifylline—Feeling abnormal—Memantine—Alzheimer's disease	0.00105	0.00198	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00104	0.00196	CcSEcCtD
Pentoxifylline—Hypersensitivity—Donepezil—Alzheimer's disease	0.00104	0.00195	CcSEcCtD
Pentoxifylline—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00103	0.00193	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00102	0.00192	CcSEcCtD
Pentoxifylline—Urticaria—Memantine—Alzheimer's disease	0.00101	0.00191	CcSEcCtD
Pentoxifylline—Abdominal pain—Memantine—Alzheimer's disease	0.00101	0.0019	CcSEcCtD
Pentoxifylline—Body temperature increased—Memantine—Alzheimer's disease	0.00101	0.0019	CcSEcCtD
Pentoxifylline—Asthenia—Donepezil—Alzheimer's disease	0.00101	0.0019	CcSEcCtD
Pentoxifylline—Pruritus—Donepezil—Alzheimer's disease	0.000994	0.00187	CcSEcCtD
Pentoxifylline—Urticaria—Rivastigmine—Alzheimer's disease	0.000992	0.00186	CcSEcCtD
Pentoxifylline—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000987	0.00186	CcSEcCtD
Pentoxifylline—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000987	0.00186	CcSEcCtD
Pentoxifylline—Diarrhoea—Donepezil—Alzheimer's disease	0.000962	0.00181	CcSEcCtD
Pentoxifylline—Hypersensitivity—Memantine—Alzheimer's disease	0.00094	0.00177	CcSEcCtD
Pentoxifylline—Dizziness—Donepezil—Alzheimer's disease	0.000929	0.00175	CcSEcCtD
Pentoxifylline—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00092	0.00173	CcSEcCtD
Pentoxifylline—Asthenia—Memantine—Alzheimer's disease	0.000915	0.00172	CcSEcCtD
Pentoxifylline—Pruritus—Memantine—Alzheimer's disease	0.000903	0.0017	CcSEcCtD
Pentoxifylline—Asthenia—Rivastigmine—Alzheimer's disease	0.000896	0.00168	CcSEcCtD
Pentoxifylline—Vomiting—Donepezil—Alzheimer's disease	0.000894	0.00168	CcSEcCtD
Pentoxifylline—Rash—Donepezil—Alzheimer's disease	0.000886	0.00167	CcSEcCtD
Pentoxifylline—Dermatitis—Donepezil—Alzheimer's disease	0.000885	0.00166	CcSEcCtD
Pentoxifylline—Pruritus—Rivastigmine—Alzheimer's disease	0.000883	0.00166	CcSEcCtD
Pentoxifylline—Headache—Donepezil—Alzheimer's disease	0.00088	0.00166	CcSEcCtD
Pentoxifylline—Diarrhoea—Memantine—Alzheimer's disease	0.000873	0.00164	CcSEcCtD
Pentoxifylline—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000854	0.00161	CcSEcCtD
Pentoxifylline—Dizziness—Memantine—Alzheimer's disease	0.000844	0.00159	CcSEcCtD
Pentoxifylline—Nausea—Donepezil—Alzheimer's disease	0.000835	0.00157	CcSEcCtD
Pentoxifylline—Dizziness—Rivastigmine—Alzheimer's disease	0.000825	0.00155	CcSEcCtD
Pentoxifylline—Vomiting—Memantine—Alzheimer's disease	0.000811	0.00153	CcSEcCtD
Pentoxifylline—Rash—Memantine—Alzheimer's disease	0.000805	0.00151	CcSEcCtD
Pentoxifylline—Dermatitis—Memantine—Alzheimer's disease	0.000804	0.00151	CcSEcCtD
Pentoxifylline—Headache—Memantine—Alzheimer's disease	0.000799	0.0015	CcSEcCtD
Pentoxifylline—Vomiting—Rivastigmine—Alzheimer's disease	0.000794	0.00149	CcSEcCtD
Pentoxifylline—Rash—Rivastigmine—Alzheimer's disease	0.000787	0.00148	CcSEcCtD
Pentoxifylline—Dermatitis—Rivastigmine—Alzheimer's disease	0.000786	0.00148	CcSEcCtD
Pentoxifylline—Headache—Rivastigmine—Alzheimer's disease	0.000782	0.00147	CcSEcCtD
Pentoxifylline—Nausea—Memantine—Alzheimer's disease	0.000758	0.00142	CcSEcCtD
Pentoxifylline—Nausea—Rivastigmine—Alzheimer's disease	0.000741	0.00139	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	8.91e-05	0.000309	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—F2—Alzheimer's disease	8.83e-05	0.000306	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—S100B—Alzheimer's disease	8.8e-05	0.000305	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	8.75e-05	0.000303	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—F2—Alzheimer's disease	8.73e-05	0.000302	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PLCB1—Alzheimer's disease	8.68e-05	0.000301	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGFR—Alzheimer's disease	8.65e-05	0.0003	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CREB1—Alzheimer's disease	8.59e-05	0.000298	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PLCB1—Alzheimer's disease	8.58e-05	0.000297	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.57e-05	0.000297	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADAM10—Alzheimer's disease	8.45e-05	0.000293	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL2—Alzheimer's disease	8.41e-05	0.000291	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	8.4e-05	0.000291	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	8.39e-05	0.000291	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF2—Alzheimer's disease	8.38e-05	0.00029	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NPY—Alzheimer's disease	8.35e-05	0.000289	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IAPP—Alzheimer's disease	8.3e-05	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1R—Alzheimer's disease	8.1e-05	0.000281	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGFR—Alzheimer's disease	8.1e-05	0.000281	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CRH—Alzheimer's disease	8.06e-05	0.000279	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CREB1—Alzheimer's disease	8.05e-05	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGFR—Alzheimer's disease	8e-05	0.000277	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—S100B—Alzheimer's disease	7.99e-05	0.000277	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CREB1—Alzheimer's disease	7.95e-05	0.000275	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR5—Alzheimer's disease	7.95e-05	0.000275	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADAM10—Alzheimer's disease	7.91e-05	0.000274	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL2—Alzheimer's disease	7.87e-05	0.000273	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.84e-05	0.000271	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADAM10—Alzheimer's disease	7.82e-05	0.000271	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL2—Alzheimer's disease	7.78e-05	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	7.78e-05	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LPL—Alzheimer's disease	7.76e-05	0.000269	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MEF2C—Alzheimer's disease	7.69e-05	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NPS—Alzheimer's disease	7.64e-05	0.000265	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF2—Alzheimer's disease	7.61e-05	0.000263	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	7.6e-05	0.000263	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRKCG—Alzheimer's disease	7.55e-05	0.000262	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—F2—Alzheimer's disease	7.51e-05	0.00026	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTK2B—Alzheimer's disease	7.49e-05	0.00026	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—S100B—Alzheimer's disease	7.48e-05	0.000259	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—Alzheimer's disease	7.43e-05	0.000257	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—S100B—Alzheimer's disease	7.39e-05	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGF—Alzheimer's disease	7.35e-05	0.000255	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1R—Alzheimer's disease	7.35e-05	0.000255	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GAB2—Alzheimer's disease	7.29e-05	0.000252	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SST—Alzheimer's disease	7.29e-05	0.000252	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK2—Alzheimer's disease	7.29e-05	0.000252	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CALM1—Alzheimer's disease	7.26e-05	0.000251	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GSK3A—Alzheimer's disease	7.22e-05	0.00025	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR5—Alzheimer's disease	7.15e-05	0.000248	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA4—Alzheimer's disease	7.15e-05	0.000248	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF2—Alzheimer's disease	7.12e-05	0.000247	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APP—Alzheimer's disease	7.1e-05	0.000246	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LPL—Alzheimer's disease	7.05e-05	0.000244	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF2—Alzheimer's disease	7.04e-05	0.000244	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—Alzheimer's disease	7e-05	0.000243	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MEF2C—Alzheimer's disease	6.99e-05	0.000242	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	6.98e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1R—Alzheimer's disease	6.89e-05	0.000239	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRKCG—Alzheimer's disease	6.85e-05	0.000237	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—Alzheimer's disease	6.85e-05	0.000237	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—F2—Alzheimer's disease	6.82e-05	0.000236	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1R—Alzheimer's disease	6.8e-05	0.000236	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	6.72e-05	0.000233	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLCB1—Alzheimer's disease	6.7e-05	0.000232	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGF—Alzheimer's disease	6.68e-05	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LPL—Alzheimer's disease	6.6e-05	0.000229	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MEF2C—Alzheimer's disease	6.54e-05	0.000227	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CALM1—Alzheimer's disease	6.53e-05	0.000226	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LPL—Alzheimer's disease	6.52e-05	0.000226	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—Alzheimer's disease	6.51e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LEP—Alzheimer's disease	6.51e-05	0.000225	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR5—Alzheimer's disease	6.5e-05	0.000225	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MEF2C—Alzheimer's disease	6.46e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CAV1—Alzheimer's disease	6.45e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRKCG—Alzheimer's disease	6.42e-05	0.000222	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	6.37e-05	0.000221	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—Alzheimer's disease	6.36e-05	0.00022	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRKCG—Alzheimer's disease	6.34e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGFR—Alzheimer's disease	6.25e-05	0.000217	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGF—Alzheimer's disease	6.25e-05	0.000217	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ESR1—Alzheimer's disease	6.21e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CREB1—Alzheimer's disease	6.21e-05	0.000215	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGF—Alzheimer's disease	6.18e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—F2—Alzheimer's disease	6.14e-05	0.000213	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADAM10—Alzheimer's disease	6.11e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR5—Alzheimer's disease	6.08e-05	0.000211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL2—Alzheimer's disease	6.08e-05	0.000211	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLD3—Alzheimer's disease	6.08e-05	0.000211	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.08e-05	0.00021	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR5—Alzheimer's disease	6.01e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	6.01e-05	0.000208	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.01e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—Alzheimer's disease	5.95e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CALM1—Alzheimer's disease	5.93e-05	0.000205	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LEP—Alzheimer's disease	5.91e-05	0.000205	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—Alzheimer's disease	5.91e-05	0.000205	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—Alzheimer's disease	5.88e-05	0.000204	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CAV1—Alzheimer's disease	5.85e-05	0.000203	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	5.83e-05	0.000202	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—S100B—Alzheimer's disease	5.77e-05	0.0002	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.69e-05	0.000197	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ESR1—Alzheimer's disease	5.64e-05	0.000195	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GSK3B—Alzheimer's disease	5.64e-05	0.000195	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	5.61e-05	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CREB1—Alzheimer's disease	5.59e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—F2—Alzheimer's disease	5.57e-05	0.000193	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INS—Alzheimer's disease	5.56e-05	0.000193	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CALM1—Alzheimer's disease	5.55e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LEP—Alzheimer's disease	5.53e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—Alzheimer's disease	5.53e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—Alzheimer's disease	5.5e-05	0.00019	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CALM1—Alzheimer's disease	5.49e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CAV1—Alzheimer's disease	5.48e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL2—Alzheimer's disease	5.47e-05	0.00019	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LEP—Alzheimer's disease	5.47e-05	0.000189	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—Alzheimer's disease	5.47e-05	0.000189	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.45e-05	0.000189	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CAV1—Alzheimer's disease	5.42e-05	0.000188	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ND1—Alzheimer's disease	5.42e-05	0.000188	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—Alzheimer's disease	5.38e-05	0.000186	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1R—Alzheimer's disease	5.32e-05	0.000184	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—Alzheimer's disease	5.3e-05	0.000184	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.29e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ESR1—Alzheimer's disease	5.28e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ESR1—Alzheimer's disease	5.22e-05	0.000181	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—F2—Alzheimer's disease	5.22e-05	0.000181	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—F2—Alzheimer's disease	5.16e-05	0.000179	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GSK3B—Alzheimer's disease	5.12e-05	0.000177	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.11e-05	0.000177	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LPL—Alzheimer's disease	5.1e-05	0.000177	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CREB1—Alzheimer's disease	5.08e-05	0.000176	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MEF2C—Alzheimer's disease	5.05e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INS—Alzheimer's disease	5.05e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH1—Alzheimer's disease	5.05e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL2—Alzheimer's disease	4.97e-05	0.000172	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.96e-05	0.000172	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—Alzheimer's disease	4.88e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—Alzheimer's disease	4.88e-05	0.000169	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.84e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGF—Alzheimer's disease	4.83e-05	0.000167	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GSK3B—Alzheimer's disease	4.79e-05	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CREB1—Alzheimer's disease	4.75e-05	0.000165	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GSK3B—Alzheimer's disease	4.74e-05	0.000164	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INS—Alzheimer's disease	4.73e-05	0.000164	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CREB1—Alzheimer's disease	4.7e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR5—Alzheimer's disease	4.7e-05	0.000163	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INS—Alzheimer's disease	4.67e-05	0.000162	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL2—Alzheimer's disease	4.65e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL2—Alzheimer's disease	4.6e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—Alzheimer's disease	4.6e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—Alzheimer's disease	4.57e-05	0.000158	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—Alzheimer's disease	4.52e-05	0.000157	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—Alzheimer's disease	4.43e-05	0.000153	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CALM1—Alzheimer's disease	4.29e-05	0.000149	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LEP—Alzheimer's disease	4.27e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—Alzheimer's disease	4.27e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CAV1—Alzheimer's disease	4.23e-05	0.000147	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.18e-05	0.000145	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.17e-05	0.000145	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—Alzheimer's disease	4.15e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—Alzheimer's disease	4.14e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—Alzheimer's disease	4.11e-05	0.000142	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—Alzheimer's disease	4.1e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ESR1—Alzheimer's disease	4.08e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—F2—Alzheimer's disease	4.03e-05	0.00014	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.94e-05	0.000137	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK8—Alzheimer's disease	3.8e-05	0.000132	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.8e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—Alzheimer's disease	3.79e-05	0.000131	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.79e-05	0.000131	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—Alzheimer's disease	3.76e-05	0.00013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—Alzheimer's disease	3.73e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.7e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.67e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INS—Alzheimer's disease	3.65e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.59e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.55e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—Alzheimer's disease	3.53e-05	0.000122	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—Alzheimer's disease	3.52e-05	0.000122	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—Alzheimer's disease	3.51e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.51e-05	0.000122	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—Alzheimer's disease	3.5e-05	0.000121	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TPI1—Alzheimer's disease	3.49e-05	0.000121	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CHAT—Alzheimer's disease	3.49e-05	0.000121	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—Alzheimer's disease	3.48e-05	0.00012	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—Alzheimer's disease	3.46e-05	0.00012	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK8—Alzheimer's disease	3.45e-05	0.00012	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—Alzheimer's disease	3.44e-05	0.000119	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOB—Alzheimer's disease	3.35e-05	0.000116	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK8—Alzheimer's disease	3.23e-05	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—Alzheimer's disease	3.23e-05	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—Alzheimer's disease	3.22e-05	0.000112	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	3.22e-05	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—Alzheimer's disease	3.2e-05	0.000111	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK8—Alzheimer's disease	3.2e-05	0.000111	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—Alzheimer's disease	3.19e-05	0.000111	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—Alzheimer's disease	3.19e-05	0.00011	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.18e-05	0.00011	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.15e-05	0.000109	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—A2M—Alzheimer's disease	3.11e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—Alzheimer's disease	2.99e-05	0.000103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—Alzheimer's disease	2.95e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—Alzheimer's disease	2.93e-05	0.000101	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.77e-05	9.61e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.74e-05	9.5e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—Alzheimer's disease	2.74e-05	9.5e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.72e-05	9.41e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—Alzheimer's disease	2.71e-05	9.38e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.71e-05	9.37e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.7e-05	9.35e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.67e-05	9.27e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—Alzheimer's disease	2.65e-05	9.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.54e-05	8.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.54e-05	8.78e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.5e-05	8.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.49e-05	8.63e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.49e-05	8.61e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—Alzheimer's disease	2.43e-05	8.42e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—Alzheimer's disease	2.41e-05	8.35e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.36e-05	8.17e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.31e-05	7.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—Alzheimer's disease	2.26e-05	7.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—Alzheimer's disease	2.24e-05	7.76e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—Alzheimer's disease	2.23e-05	7.73e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.22e-05	7.71e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—Alzheimer's disease	2.21e-05	7.64e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.18e-05	7.56e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.16e-05	7.47e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.12e-05	7.33e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—Alzheimer's disease	2.07e-05	7.16e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—Alzheimer's disease	2.04e-05	7.07e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—Alzheimer's disease	2.04e-05	7.05e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—Alzheimer's disease	1.91e-05	6.6e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—Alzheimer's disease	1.88e-05	6.52e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.86e-05	6.44e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.85e-05	6.41e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—Alzheimer's disease	1.74e-05	6.04e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.69e-05	5.86e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—Alzheimer's disease	1.59e-05	5.53e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.52e-05	5.28e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.47e-05	5.1e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.42e-05	4.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.42e-05	4.91e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.41e-05	4.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.24e-05	4.28e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INS—Alzheimer's disease	1.21e-05	4.2e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.06e-05	3.68e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.72e-06	3.37e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.88e-06	1.69e-05	CbGpPWpGaD
